TTrialPathMatch Me to Trials
← Back to trials
RecruitingEndometriosis (Diagnosis)

Observational Study on the Use of Ultrasound to Recognize Superficial Endometriosis in a Specific Area of the Pelvis (the Uterosacral Ligaments)

Eligible age

18–50 yrs

Accepts

Women

Locations

0 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

An observational, prospective, multicenter study conducted on patients of childbearing age undergoing laparoscopic surgery for early-stage benign or malignant gynecological disease. The study does not include changes to the standard care pathway.

Sponsor: Casa di Cura Dott. Pederzoli

You may qualify if…

  • patients who need to undergo gynecological surgery with a laparoscopic approach for benign pathology (endometriosis, uterine fibroids, adenomyosis, chronic pelvic pain, benign ovarian cysts) or non-advanced malignant pathology (stage I endometrium and cervix, stage I and II ovary).
  • patients who performed a level II gynecological ultrasound with an experienced operator in the preoperative pathway.
  • technical possibility of performing a transvaginal ultrasound and the patient's willingness to undergo such an investigation.
  • patients of childbearing age (18 - 50 years).
  • Signing of informed consent.

You may not qualify if…

  • presence of endometriosis deeply infiltrating the posterior compartment. This may interfere with the interpretation of uterosacral ligament (LUS) thickness as a specific marker of superficial endometriosis
  • technical impossibility of performing a transvaginal ultrasound (patient virgo, patient refusal).
  • incomplete ultrasound evaluation of the uterosacral ligaments for anatomical reasons or for the presence of endometriosis nodules from other sites with partial involvement of the LUS (uterosacral ligament).
  • advanced malignant disease (\>Stage I for endometrium and cervix, \> Stage II for ovary)
  • pelvic organ prolapse
  • PID or other pelvic inflammatory diseases
  • medical emergencies (ovarian torsion, hemoperitoneum)
  • postmenopausal patients

Source: ClinicalTrials.gov · NCT07427849 · last updated 2026-02-25